-
公开(公告)号：US20220062415A1
公开(公告)日：2022-03-03
申请号：US17524516
申请日：2021-11-11
发明人： Hong Xie , Andrew Cakana
IPC分类号： A61K39/395 , A61K31/198 , A61K31/573 , C07K16/28 , A61K9/00 , A61K47/12 , A61K47/02 , A61K47/26 , A61K47/42 , A61K47/22 , A61K47/20 , A61P35/00 , A61K31/69 , G06Q30/00 , G06Q30/06 , G06Q30/02
摘要： Described herein are methods of treating multiple myeloma with clinically proven safe and effective amounts of an antibody that specifically recognizes CD38 with bortezomib, melphalan, and prednisone. Also described are methods of selling or offering for sale an antibody that specifically recognizes CD38 or pharmaceutical compositions thereof with bortezomib, melphalan, and prednisone.
-
公开(公告)号：US20190298827A1
公开(公告)日：2019-10-03
申请号：US16374031
申请日：2019-04-03
发明人： Hong Xie , Andrew Cakana
IPC分类号： A61K39/395 , A61K31/69 , A61K31/198 , A61K31/573 , C07K16/28 , A61K9/00 , A61K47/12 , A61K47/02 , A61K47/26 , A61K47/42 , A61K47/22 , A61K47/20 , A61P35/00
摘要： Described herein are methods of treating multiple myeloma with clinically proven safe and effective amounts of an antibody that specifically recognizes CD38 with bortezomib, melphalan, and prednisone. Also described are methods of selling or offering for sale an antibody that specifically recognizes CD38 or pharmaceutical compositions thereof with bortezomib, melphalan, and prednisone.
-
搜索结果
2 条记录 (耗时 0.017 秒)
